Paragonix President Lisa Anderson Named 2026 CNBC Changemaker Amid Expansion Push

Event summary

  • Paragonix President Dr. Lisa Anderson named to 2026 CNBC Changemakers list, recognizing 50 women leaders transforming industries.
  • Anderson led Paragonix through $477M acquisition by Getinge in 2024, accelerating global expansion.
  • Company launched KidneyVault Portable Renal Perfusion System, completing its solid organ preservation portfolio.
  • Paragonix now offers FDA-cleared and CE-marked preservation technologies across all major solid organs.

The big picture

Paragonix's recognition comes as organ transplant technology faces increasing demand due to growing transplant waiting lists. The company's completion of its solid organ preservation portfolio positions it as a key player in an industry where preservation time directly impacts patient outcomes. The CNBC honor also highlights the strategic value of female leadership in medtech innovation, particularly in execution of large-scale acquisitions.

What we're watching

Integration Challenges
How Paragonix will maintain innovation pace under Getinge ownership after $477M acquisition.
Market Penetration
The pace at which KidneyVault adoption will grow amid 100,000+ US patients awaiting kidney transplants.
Regulatory Dynamics
Whether Paragonix can sustain FDA/CE approval momentum for new organ preservation technologies.

Related topics

Acquisition